United Leukodystrophy Foundation

What United Leukodystrophy Foundation does

United Leukodystrophy Foundation (ULF) is a non-profit voluntary health organization incorporated in 1982 and headquartered in Chicago, Illinois. ULF supports patients and families affected by leukodystrophy — a group of over 50 rare genetic disorders affecting the brain's white matter — through a combination of disease education, physician referrals, virtual and in-person support groups, caregiver resources, financial assistance information, and an annual Scientific Symposium and Family Conference that convenes patients, clinicians, and researchers. The foundation also funds medical research directly through its annual Research Grant Program, having disbursed over $765,000 to leukodystrophy researchers since 2010, including a $33,000 grant for gene therapy research in H-ABC awarded in December 2025.

The organization's core products and services are community- and information-centric rather than technology-based. Core offerings include the Research Grant Program, the Find a Physician referral service, Genetic Counseling resources, Clinical Trials information, Virtual Support Groups, the State Ambassador Program, and the annual conference. It also runs awareness campaigns such as LeukoAware (September Leukodystrophy Awareness Month) and Rare Disease Day, and facilitates partnerships with pharmaceutical sponsors (e.g., Minoryx Therapeutics' NEXUS trial) and genetic testing services (Invitae) to support patient recruitment and early diagnosis.

ULF generates revenue entirely through donations and fundraising — individual donations, memorial and honorarium gifts, corporate matching gift programs, community-organized fundraisers (5K runs, restaurant nights), and raffle events. All patient-facing services are provided free of charge. The organization is governed by a Board of Directors and a Medical and Scientific Advisory Board, with President Robert Rauner leading the foundation alongside recently expanded board membership (seven new directors added circa 2020). ULF maintains a global reach through its website, virtual support groups, and international physician referral network, despite operating from a single Chicago office with a small (1-10) staff.

Name

United Leukodystrophy Foundation

Legal name

United Leukodystrophy Foundation

Website

https://ulf.org

Company type

Private

Founded year

1982

Operating status

Operating

Headcount range

1–10 employees

Short description

United Leukodystrophy Foundation is a Chicago-based non-profit incorporated in 1982 that supports patients and families affected by over 50 rare leukodystrophy disorders through education, physician referrals, support groups, and annual research grants totaling more than $765,000 since 2010.

Ownership category

akta.pro rank

Product category

Rare Disease Patient Support Services

NAICS

Voluntary Health Organizations (813212), Grantmaking and Giving Services (81321)

SIC

Services-Social Services (8300), Services-Membership Organizations (8600)

akta.pro primary industry

Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS) (BPAGACAA)

akta.pro secondary industry

Rare Disease & Special Needs Support Organizations (BPAGACAM)

Keywords

• Rare disease patient support
• Medical research funding
• Patient advocacy services
• Genetic disorder support
• Nonprofit health organization

Headquarters

HQ city

Chicago

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Individual Donations: Individual donors contribute to ULF through the organization's website donation portal. The foundation receives both general donations and designated gifts for specific purposes such as research grants or programming.
2. Memorial and Honorarium Donations: Donations made in memory or honor of individuals, which are publicly acknowledged on the ULF website. These constitute a significant portion of annual contributions.
3. Corporate Matching Gifts: Corporate matching gift programs where companies match employee donations, typically at 1:1 to 4:1 ratios, amplifying individual contributions.
4. Community Fundraising Events: Third-party fundraising events organized by volunteers including restaurant fundraiser nights, 5K runs/walks, raffles, and other community events. ULF provides marketing support and guidance for these initiatives.
5. Raffle and Drawing Fundraisers: Special raffle events such as the Magical Memories Disney Raffle where tickets are sold to raise funds. For example, tickets at $50 each with prizes including Disney gift cards and travel packages.

Go-to-market motion3 records

Distribution channels6 records

Marketing channels13 records

Core offering

The United Leukodystrophy Foundation (ULF) is a non-profit voluntary health organization that funds medical research on leukodystrophies and provides patients and families with disease information, physician referrals, peer support, and community-building programs. Its core deliverables include an annual Research Grant Program, the Scientific Symposium and Family Conference, Find a Physician referrals, Virtual Support Groups, a State Ambassador Program, and awareness campaigns including LeukoAware and Rare Disease Day. All services are offered free of charge to patients and families, funded through donations, matching gifts, and community fundraising events.

Product overview

The United Leukodystrophy Foundation (ULF) is a non-profit voluntary health organization incorporated in 1982, offering a suite of support and educational services rather than a traditional product. The core offerings include the Research Grant Program funding medical research, a Communication Network connecting families, the annual Scientific Symposium & Family Conference, Find a Physician referral service, Virtual Support Groups, and a State Ambassador Program. Additional resources include Genetic Counseling resources, Clinical Trials information, Financial Assistance, Caregiver Support services, and awareness programs including LeukoAware (Leukodystrophy Awareness Month) and Rare Disease Day participation. The Foundation serves newly diagnosed patients and families navigating leukodystrophy through unified collaboration with advocacy groups, medical professionals, and pharma/biotech companies.

Differentiator

Problem solved

Functional benefit

Products and services

• ULF Research Grant Program
• Communication Network
• Scientific Symposium & Family Conference
• Find a Physician Service
• Virtual Support Groups
• State Ambassador Program
• Clinical Trials Information
• Financial Assistance Program
• Caregiver Support
• Leukodystrophy Awareness Month (LeukoAware)
• Rare Disease Day

Named customers7 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Eight partnerships are on record, tiered core and minor.

• National Organization for Rare Disorders (NORD)coreStrategic or Co-development PartnerULF is a member of NORD, the leading advocacy organization for rare disease patients in the United States. This membership provides access to advocacy resources, policy engagement, and collaborative opportunities with other rare disease organizations.
• Guidestar (Candid)minorOthersULF participates in Guidestar's transparency program, displaying the Transparency Seal to demonstrate nonprofit accountability and financial transparency to donors.
• InvitaeminorOthersInvitae offers no-cost genetic testing for families in the United States, Canada, and Australia who are at risk of a leukodystrophy diagnosis. ULF refers patients to this service through its genetic counseling resources page.
• Montreal Children's Hospital FoundationminorStrategic or Co-development PartnerPartnership featuring Dr. Genevieve Bernard, a world-renowned leukodystrophy expert at McGill University and Montreal Children's Hospital. ULF shares educational content and connects patients with international experts.
• Global DARE FoundationcoreStrategic or Co-development PartnerGlobal DARE Foundation (Defeat Adult Refsum Everywhere) was founded by Kristie DeMarco, who also serves on ULF's Board of Directors. The organizations collaborate on advocacy and research for Refsum disease, a type of leukodystrophy.
• Minoryx TherapeuticsminorStrategic or Co-development PartnerULF promotes Minoryx Therapeutics' NEXUS clinical trial for cerebral X-linked adrenoleukodystrophy (cALD), helping recruit patients for the phase 2 study of leriglitazone.
• VWM Families FoundationminorStrategic or Co-development PartnerFounded by the Buck family after their son Sam was diagnosed with Vanishing White Matter disease. ULF connected the family with resources and community; the foundation now funds VWM research internationally.
• Corporate Matching Gift PartnersminorGTM or Marketing PartnerVarious corporations participate in employee matching gift programs that match employee donations to ULF, typically at 1:1 to 4:1 ratios, amplifying donation impact.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Market position

Competitive moat4 records

Key highlights7 records

Customer concentration

• Xx.com/ulfunited
• YouTubeyoutube.com/c/ULFOffice
• Facebookfacebook.com/UlfUnited
• LinkedInlinkedin.com/company/ulfunited
• Instagraminstagram.com/ulfunited

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about United Leukodystrophy Foundation